The aim of this study was to assess health-related quality of life (HRQOL) among chronic hepatitis B (CHB) patients in Turkey and to study related factors. This multicenter study was carried out between January 01 and April 15, 2015 in Turkey in 57 centers. Adults were enrolled and studied in three groups. Group 1: Inactive HBsAg carriers, Group 2: CHB patients receiving antiviral therapy, Group 3: CHB patients who were neither receiving antiviral therapy nor were inactive HBsAg carriers. Study data was collected by face-to-face interviews using a standardized questionnaire, Short Form-36 (SF-36) and Hepatitis B Quality of Life (HBQOL). Values equivalent to p < 0.05 in analyses were accepted as statistically significant. Four thousand two hundred fifty-seven patients with CHB were included in the study. Two thousand five hundred fifty-nine (60.1 %) of the patients were males. Groups 1, 2 and 3, consisted of 1529 (35.9 %), 1721 (40.4 %) and 1007 (23.7 %) patients, respectively. The highest value of HRQOL was found in inactive HBsAg carriers. We found that total HBQOL score increased when antiviral treatment was used. However, HRQOL of CHB patients varied according to their socio-demographic properties. Regarding total HBQOL score, a higher significant level of HRQOL was determined in inactive HBV patients when matched controls with the associated factors were provided. The HRQOL score of CHB patients was higher than expected and it can be worsen when the disease becomes active. Use of an antiviral therapy can contribute to increasing HRQOL of patients.
AHAhmet Refik KonyalıAffiliationsSağlık Bilimleri Üniversitesi (SBÜ) İstanbul Eğitim Araştırma Hastanesi
Ahmet Refik KonyalıAffiliationsSağlık Bilimleri Üniversitesi (SBÜ) İstanbul Eğitim Araştırma Hastanesi
NHNagehan Didem SarıAffiliationsSağlık Bilimleri Üniversitesi (SBÜ) İstanbul Eğitim Araştırma Hastanesi
Nagehan Didem SarıAffiliationsSağlık Bilimleri Üniversitesi (SBÜ) İstanbul Eğitim Araştırma Hastanesi
Objective: Pneumocystis jiroveci pneumonia (PJP) is a common opportunistic infection in human immunodeficiency virus (HIV) infection cases. This study aimed to investigate the mortality rate and the factors affecting mortality in HIV-infected PJP cases followed in our clinic. Methods: In this study HIV (+) cases followed up in our clinic between 2012-2019 were included. Age, sex, comorbidity status, LDH, CD4, lymphocyte, albumin, values, and blood gas results of these patients were recorded at the time of diagnosis. Results: Twenty-eight patients with the diagnosis of HIV-infected PJP were included in the study. The mean age of the patients was 45.7 years, and the male ratio was 78.6% (18/28). The overall hospital mortality rate was 35.7% (10/28)among the cases. Conclusions: As a result, performing studies involving many patients may be beneficial in these patients for diagnosis,follow-up and early treatment.
Objective: Tuberculosis (TB) is the most important opportunistic infection and one of the leading causes of death in individuals living with human immunodeficiency virus (HIV). Treatment of HIV/TB coinfected patients is more complicated than that of individuals living with HIV only. We aimed to determine the epidemiological characteristics of HIV/TB coinfected patients and the factors affecting TB treatment success. Methods: This retrospective study was conducted between January 2006 and December 2022. Among individuals living with HIV, those aged ≥18 years and with active tuberculosis were included in the study. Sociodemographic, clinical and laboratory findings of HIV/TB coinfected patients were recorded from their files. Patients were divided into two groups according to TB treatment response. The statistical significance level was accepted as p <0.05 in comparison of the two groups. Results: Active TB disease was detected in 78 (%8.4) of 931 individuals living with HIV. A total of 74 patients were included in the study. The average age of the patients was 42.84±12.91 years (range 20-78); 64 (86.5%) were male, and 32 (43.2%) were unemployed. Before TB treatment, 36 (48.6%) of the individuals living with HIV had CD4+ <100 cells/mm3, 10 (13.5%) had negative viral load and only 12 (16.2%) had received antiretroviral treatment (ART). Of these patients, 42 (56.8%) were evaluated as pulmonary TB and 32 (43.2%) as extrapulmonary TB. TB treatment was successful in 49 (%66.2) of the patients; 15 (%20.3) died, 5 (%6.8) received insufficient treatment, 2 (%2.7) were lost to follow-up, and 3 (%4.1) were transferred to another centre. Unsuccessful TB treatment outcomes were associated with a higher mortality rate (20.3%) and increasing age (p<0.05). Conclusion: In our study, the success rate of TB treatment in HIV/TB coinfected individuals was determined as 66.2%. Our findings were lower than World Health Organization targets. The high mortality rate and the advancing age of the patients were determined to be the most critical factors affecting the success of the TB treatment. We conclude that more attention should be paid to HIV/TB coinfected patients, strategies should be developed to ensure early diagnosis, and more comprehensive and prospective studies on this subject need to be conducted in our country.
Background: Married Men who have Sex with Men (MSM) constitute a bridge popu-lation for HIV diffusion into low-risk groups, with spousal non-disclosure rates exceeding 60% in China. It will increase the risk of secondary transmission within families. Despite the timely implementation of evidence-based interventions, reducing MTCT rates to below 2% in China, residual pediatric infections persist. Introduction: Isolated anti-HBc positivity, defined by the absence of HBsAg and anti-HBs, may reflect prior exposure to HBV, occult infection, or a false-positive result. This study aimed to assess the prevalence of isolated anti-HBc positivity and its associated factors among PLWH in Istanbul, Turkey. Methods: This retrospective cross-sectional study included adult People Living With HIV (PLWH) who underwent HBV serological testing between January 2000 and December 2019 at a tertiary hospital in Istanbul. Demographic and clinical characteristics were analyzed. Results: Among 386 PLWH, 8.8% (n = 34) had isolated anti-HBc positivity. Compared with HBV-seronegative PLWH (n = 194), these patients were older (48 [IQR 42-54] vs. 42 [35-50] years; p = 0.007), more likely to have BMI ≥ 25 kg/m² (p = 0.025), and to report smoking (p = 0.041), based on available data. Pre-ART HBV DNA testing was available in 13/34 (38.2%) pa-tients with isolated anti-HBc, and all tested samples were HBV DNA–negative. Discussion: Isolated anti-HBc prevalence was 8.8% in PLWH; older age, BMI ≥25 kg/m², and smoking were more common in this group. Although no HBV DNA was detected in the tested subset, limited HBV DNA testing precluded estimation of OBI prevalence in this cohort. Conclusion: Recognition of isolated anti-HBc positivity and occult HBV infection is important for ART selection and patient follow-up. Although isolated anti-HBc positivity was identified in 8.8% of this cohort, more systematic and risk-stratified HBV DNA assessment is needed to better define the true burden of occult HBV infection.